PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
17.97%
Growth of 17.97% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
25.11%
Cost growth exceeding 1.5x Healthcare median of 0.81%. Jim Chanos would check for structural cost disadvantages.
-9.53%
Gross profit decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
-23.31%
Margin decline while Healthcare median is 0.00%. Seth Klarman would investigate competitive position.
188.72%
R&D change of 188.72% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-32.89%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
48.76%
Marketing expense change of 48.76% versus flat Healthcare spending. Walter Schloss would verify adequacy.
156.00%
Other expenses change of 156.00% versus flat Healthcare costs. Walter Schloss would verify efficiency.
-8.86%
Operating expenses reduction while Healthcare median is 7.77%. Seth Klarman would investigate advantages.
10.87%
Total costs growth 1.25-1.5x Healthcare median of 7.89%. Guy Spier would scrutinize spending.
41.73%
Interest expense change of 41.73% versus flat Healthcare costs. Walter Schloss would verify control.
48.75%
D&A growth exceeding 1.5x Healthcare median of 1.34%. Jim Chanos would check for overinvestment.
94.19%
EBITDA growth while Healthcare declines. Peter Lynch would examine advantages.
131.61%
Margin change of 131.61% versus flat Healthcare. Walter Schloss would verify quality.
-37.46%
Operating income decline while Healthcare median is -6.51%. Seth Klarman would investigate causes.
-16.53%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
152.56%
Other expenses change of 152.56% versus flat Healthcare. Walter Schloss would verify control.
113.77%
Pre-tax income growth while Healthcare declines. Peter Lynch would examine advantages.
111.67%
Margin change of 111.67% versus flat Healthcare. Walter Schloss would verify quality.
-1.72%
Tax expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
111.86%
Net income growth while Healthcare declines. Peter Lynch would examine advantages.
110.06%
Margin change of 110.06% versus flat Healthcare. Walter Schloss would verify quality.
116.82%
EPS growth while Healthcare declines. Peter Lynch would examine advantages.
116.82%
Diluted EPS growth while Healthcare declines. Peter Lynch would examine advantages.
68.21%
Share count change of 68.21% versus stable Healthcare. Walter Schloss would verify approach.
68.21%
Diluted share change of 68.21% versus stable Healthcare. Walter Schloss would verify approach.